BRIEF-CTI Biopharma announces european medicines agency validation of Pacritinib
July 13, 2017 at 16:27 PM EDT
* CTI Biopharma announces european medicines agency validation of pacritinib marketing authorization application for patients with myelofibrosis who have thrombocytopenia
